We present the case of a 53-year-old female with type 2 diabetes mellitus who developed EuDKA following the abrupt discontinuation of long-term insulin therapy and transition to an SGLT2 inhibitor. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.